Yauheniya Baranchykava: Changing Lives Through Innovation in Hemophilia Care
Yauheniya Baranchykava, Hemofilia Squad Lead at Roche, shared a post on LinkedIn:
“Change the lives of people with hemophilia. That is our purpose.
This week we had the privilege of being part of the LATAM Hemophilia Meeting, along with medical specialists from all over Latin America committed to bringing the best science to their patients.
A meeting where knowledge is shared, experiences multiply and the objective is always the same: how do we get more people to access care that really transforms their lives?
Team Chile is committed to bringing science to our medical community.
Because we are convinced: the best science must reach our doctors and, through them, our patients.
Innovation in hemophilia goes far beyond reducing bleeding.
We are talking about children who can go to school without fear, adults who work, families who breathe easier.
Roche Chile’s commitment to hemophilia is real, it is continuous and it is growing.
Thanks to LATAM team, Carolina Ocampo, Josue Hidalgo G Andrea, Morales Heerlein, and their teams to make it possible and team Peru to receive us.
It was amazing!”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas LangÖ‰ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge